Editor's Note This study by investigators in the Framingham Heart Study—an ongoing, prospective cohort study evaluating cardiovascular disease risk factors—finds that systemic symptoms after COVID-19 vaccination were associated with greater antibody response than local only or no symptoms. A total of 928 of 3,200 Framingham Heart Study participants completed this…
Editor's Note This study from Columbia University Medical Center, New York City, which was presented November 5 at the ASN [American Society of Nephrology] Kidney Week 2022 in Orlando, examines the effect of kidney disease and other conditions on COVID-19 outcomes during four waves of the pandemic in New York…
Editor's Note This study from the University of Maryland, Baltimore, finds that full and partial COVID-19 vaccination reduced postoperative complications. Researchers analyzed data from patients having surgery at 1,283 VA medical facilities nationwide. Of 87,073 surgical patients, 20% were fully vaccinated, 15% were partially vaccinated, and 65% were unvaccinated. Among…
Editor's Note This study led by researchers at the VA Puget Sound Health Care System and University of Washington, Seattle, highlights the complexity of diagnosing long COVID and the challenges of caring for patients with this condition. Included in the analysis were 200 randomly sampled COVID-19 patients receiving care in…
Editor's Note JAMA Network published a research article on October 27 showing the long-term effects of COVID-19 on adults in the US and evaluating vaccine effectiveness for lasting symptoms, Health Leaders Media October 28 reports. The World Health Organization defines symptoms that last for at least 2 months post-infection as…
Editor's Note The Joint Commission announced on October 26 that it will resume intracycle calls for Disease-Specific Care (DSC) and Health Care Staffing Services (HCSS) certification programs, starting January 1, 2023. These calls, which were suspended in 2021 because of COVID-19, require programs to update their intracycle tabs in the…
Editor's Note This study led by the University of Pittsburgh School of Medicine finds that Black veterans hospitalized with COVID-19 were less likely to be treated with evidence-based treatments than White patients. A total of 43,222 veterans (12,135 Black and 31,087 White) hospitalized with COVID-19 in 130 Veterans Affairs Medical…
Editor's Note The Food and Drug Administration (FDA) on October 12 identified the recall of Jiangsu Well Biotech’s COVID-19 Ag Rapid Test Devices as Class I, the most serious. The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA. No…
Editor's Note A “sharp rise” in cases of respiratory syncytial virus (RSV) this fall is worrying staff at US hospitals, who fear what may happen to the capacity of hospitals and other healthcare facilities if RSV, influenza, and COVID-19 infections peak around the same time this winter, The Washington Post…
Editor's Note This study led by researchers from Children’s Hospital of Philadelphia examines COVID-19 vaccine hesitancy among healthcare workers (HCWs) at two large academic hospitals in Philadelphia. A total of 5,929 HCWs were surveyed, including 2,253 MDs and DOs, 582 nurse practitioners (NPs), 158 physician assistants (PAs), and 2,936 nurses.…